Harry Yan and Weiman Gao have bestowed $1 million on the Baker Institute of Public Policy to establish the interdisciplinary Neuro-Policy Program. Photo via rice.edu

A big donation to Rice University will soon help researchers better understand the workings of the human brain.

Harry Yan and Weiman Gao have bestowed $1 million on the Baker Institute of Public Policy to establish the interdisciplinary Neuro-Policy Program.

Neuro-policy is a newer field that explores how brain health and function can help to fuel economic growth.

“The Neuro-Policy Program is at the forefront of pioneering data analysis, empirical research and policy application,” says Harris Eyre, the lead for the program, as well as a senior fellow in brain health at the Baker Institute, in a news release. “Investing in evidence-based strategies for prevention, diagnosis and treatment can reduce brain and mental health disparities, optimize cognitive development and performance and foster innovation to build more resilient communities.”

Eyre describes the collective value of the human brain as “brain capital.” That’s because brains that are suffering from any number of neurodegenerative or mental health disorders (including depression, anxiety, brain injury and Alzheimer’s disease) have actually taken a toll on the U.S. economy, Eyre explains.

The Neuro-Policy Program seeks to improve brain performance, and consequently enhance economic growth, national security, and our overall standing as a nation of healthy brains. The program’s primary projects include establishing a task force to advise Texas “brain and mind” legislative efforts as well as a Texas Brain Capital Dashboard, collaborating on Texas Forward (Texas Brain Health Plan) with the UT Dallas Center for BrainHealth, thereby working toward U.S. brain capital policy and investment advances. These projects are expected to yield deliverables as early as 2026.

“The Neuro-Policy Program aims to leverage the university’s proximity to the Texas Medical Center and the institute’s strong connections to state and federal policymakers. This is an important yet underrepresented area of research that Houston is poised to lead,” says David Satterfield, the director of the Baker Institute.

Yan and Gao said in a press release that they were inspired to gift the grant funds to Eyre and his research after attending a March 28 Baker Institute event on brain health that featured U.S. Rep. Morgan Luttrell, a co-chair of the Congressional Neuroscience Caucus.

"We are honored to support Dr. Harris Eyre and the Neuro-Policy program he leads. Dr. Eyre’s work has greatly impressed us, highlighting the critical importance of brain health in our society today,” say Yan and Gao. “We hope our contribution can inspire further support and advocacy in the field, helping individuals lead healthier lives through a comprehensive approach to prevention.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

German biotech co. to relocate to Houston thanks to $4.75M CPRIT grant

money moves

Armed with a $4.75 million grant from the Cancer Prevention and Research Institute of Texas, a German biotech company will relocate to Houston to work on developing a cancer medicine that fights solid tumors.

Eisbach Bio is conducting a clinical trial of its EIS-12656 therapy at Houston’s MD Anderson Cancer Center. In September, the company announced its first patient had undergone EIS-12656 treatment. EIS-12656 works by suppressing cancer-related genome reorganization generated by DNA.

The funding from the cancer institute will support the second phase of the EIS-12656 trial, focusing on homologous recombination deficiency (HRD) tumors.

“HRD occurs when a cell loses its ability to repair double-strand DNA breaks, leading to genomic alterations and instability that can contribute to cancerous tumor growth,” says the institute.

HRD is a biomarker found in most advanced stages of ovarian cancer, according to Medical News Today. DNA constantly undergoes damage and repairs. One of the repair routes is the

homologous recombination repair (HRR) system.

Genetic mutations, specifically those in the BCRA1 and BCRA1 genes, cause an estimated 10 percent of cases of ovarian cancer, says Medical News Today.

The Cancer Prevention and Research Institute of Texas (CPRIT) says the Eisbach Bio funding will bolster the company’s “transformative approach to HRD tumor therapy, positioning Texas as a hub for innovative cancer treatments while expanding clinical options for HRD patients.”

The cancer institute also handed out grants to recruit several researchers to Houston:

  • $2 million to recruit Norihiro Goto from the Massachusetts Institute of Technology to MD Anderson.
  • $2 million to recruit Xufeng Chen from New York University to MD Anderson.
  • $2 million to recruit Xiangdong Lv from MD Anderson to the University of Texas Health Science Center at Houston.

In addition, the institute awarded:

  • $9,513,569 to Houston-based Marker Therapeutics for a first-phase study to develop T cell-based immunotherapy for treatment of metastatic pancreatic cancer.
  • $2,499,990 to Lewis Foxhall of MD Anderson for a colorectal cancer screening program.
  • $1,499,997 to Abigail Zamorano of the University of Texas Health Science Center at Houston for a cervical cancer screening program.
  • $1,497,342 to Jennifer Minnix of MD Anderson for a lung cancer screening program in Northeast Texas.
  • $449,929 to Roger Zoorob of the Baylor College of Medicine for early prevention of lung cancer.

On November 20, the Cancer Prevention and Research Institute granted funding of $89 million to an array of people and organizations involved in cancer prevention and research.

West Coast innovation organization unveils new location in Houston suburb to boost Texas tech ecosystem

plugging in

Leading innovation platform Plug and Play announced the opening of its new flagship Houston-area location in Sugar Land, which is its fourth location in Texas.

Plug and Play has accelerated over 2,700 startups globally last year with corporate partners that include Dell Technologies, Daikin, Microsoft, LG Chem, Shell, and Mercedes. The company’s portfolio includes PayPal, Dropbox, LendingClub, and Course Hero, with 8 percent of the portfolio valued at over $100 million.

The deal, which facilitated by the Sugar Land Office of Economic Development and Tourism, will bring a new office for the organization to Sugar Land Town Square with leasing and hiring between December and January. The official launch is slated for the first quarter of 2025, and will feature 15 startups announced on Selection Day.

"By expanding to Sugar Land, we’re creating a space where startups can access resources, build partnerships, and scale rapidly,” VP Growth Strategy at Plug and Play Sherif Saadawi says in a news release. “This location will help fuel Texas' innovation ecosystem, providing entrepreneurs with the tools and networks they need to drive real-world impact and contribute to the state’s technological and economic growth."

Plug and Play plans to hire four full-time equivalent employees and accelerate two startup batches per year. The focus will be on “smart cities,” which include energy, health, transportation, and mobility sectors. One Sugar Land City representative will serve as a board member.

“We are excited to welcome Plug and Play to Sugar Land,” Mayor of Sugar Land Joe Zimmerma adds. “This investment will help us connect with corporate contacts and experts in startups and businesses that would take us many years to reach on our own. It allows us to create a presence, attract investments and jobs to the city, and hopefully become a base of operations for some of these high-growth companies.”

The organization originally entered the Houston market in 2019 and now has locations in Bryan/College Station, Frisco, and Cedar Park in Texas.